specialising in hormone therapy
Infarco owns Cyndea Pharma, a pharmaceutical company located in Ólvega (Soria), leader in the manufacture of hormone therapies. Cyndea Pharma currently develops and manufactures steroid-based medications and oncology treatment for hormone-dependent tumours (e.g. breast cancer, endometrial cancer, uterine cancer or prostate cancer).Cyndea Pharma makes use of specific technology for manufacturing soft gelatine capsules.
Since 2009, Cyndea Pharma, which develops its products to subsequently sell or license them to other pharmaceutical companies, offers a comprehensive service that includes the preparation of the medicine and its manufacture through innovative products and solutions.